scispace - formally typeset
G

Glenn S. Gerhard

Researcher at Temple University

Publications -  144
Citations -  6413

Glenn S. Gerhard is an academic researcher from Temple University. The author has contributed to research in topics: Nonalcoholic fatty liver disease & Fatty liver. The author has an hindex of 37, co-authored 135 publications receiving 5305 citations. Previous affiliations of Glenn S. Gerhard include Pennsylvania State University & Geisinger Medical Center.

Papers
More filters
Journal ArticleDOI

Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease

TL;DR: Data show that hepatic DAG content in lipid droplets is the best predictor of insulin resistance in humans, and they support the hypothesis that NAFLD-associated hepatic insulin resistance is caused by an increase in hepaticDAG content, which results in activation of PKCε.
Journal ArticleDOI

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.

Aude Nicolas, +435 more
- 21 Mar 2018 - 
TL;DR: Interestingly, mutations predominantly in the N-terminal motor domain of KIF5A are causative for two neurodegenerative diseases: hereditary spastic paraplegia and Charcot-Marie-Tooth type 2.
Journal ArticleDOI

Mutation Analysis in Hereditary Hemochromatosis

TL;DR: The DNA of 147 patients of European origin clinically diagnosed with idiopathic hemochromatosis and 193 controls was examined for mutations of the HLA-H gene at nt 845 and nt 187, suggesting the presence of as yet undiscovered mutations existing in trans with 845A and in linkage disequilibrium with 187G.
Journal ArticleDOI

The Geisinger MyCode community health initiative: an electronic health record-linked biobank for precision medicine research.

TL;DR: The MyCode project has created resources that enable a new model for translational research that is faster, more flexible, and more cost-effective than traditional clinical research approaches.